Australia TGA ARTG recordLikamed Likawave Vario system - Multidisciplinary extracorporeal shock wave therapy system
Australia TGA ARTG Registered Device · Aerobe Pty Ltd · Likamed GmbH · Class IIa · Started May 24, 2024
Good Name: Aerobe Pty Ltd - Likamed Likawave Vario system - Multidisciplinary extracorporeal shock wave therapy system
- Risk Class
- Class IIa
- Product Type
- Medical device system
- ARTG Category
- General
- Start Date
- May 24, 2024
- Effective Date
- May 24, 2024
- Name
- Aerobe Pty Ltd
- Name
- Likamed GmbH
- Country
- Germany
- Address
- Raussmulhstrasse 7, Eppingen, 75031
The LiKAWAVE VARIO® 3i is a medical device for extracorporeal shock wave therapy (ESWT) and is used for shockwave treatment of patients according to the indicated (medical) indications. Administration of shockwaves requires medical knowledge and must be performed only by persons with medical training (orthopaedists, physiotherapists, medical staff etc.). Indications - • Achilles tendinitis • Calcified tendinitis • Radial and ulnar humeral epicondylitis • Patellar tendinitis • Plantar fasciitis • Chronic tendinopathies • Tibial crest syndrome • Myofascial trigger points of the motor system • Femoral head necrosis • Pseudarthrosis • Erectile disfunction
Access comprehensive regulatory information for Likamed Likawave Vario system - Multidisciplinary extracorporeal shock wave therapy system in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Aerobe Pty Ltd, manufactured by Likamed GmbH in Germany. The device registration started on May 24, 2024.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.